British American Tobacco p.l.c 6-K, filed Mar 18, 2024
British American Tobacco p.l.c. (BTI)
6-K
2024-03-18
For: 2024-03-18
View Original
Added on
April 08, 2026
About this 6-K
British American Tobacco p.l.c filed this 6-K on March 18, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
March 18, 2024
Commission File Number: 001-38159
BRITISH AMERICAN TOBACCO P.L.C.
(Translation of registrant’s name into English)
Globe House
4 Temple Place
London WC2R 2PG
United Kingdom
(Address of principal executive office)
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. (the “Registrant”) as of March 18, 2024.
The information contained in Exhibit 1 of this Form 6-K is incorporated by reference into the Form S-8 Registration Statements File Nos. 333-223678, 333-219440 and 333-237186 of the Registrant and into the Form F-3
Registration Statement File Nos. 333-265958, 333-265958-01, 333-265958-02, 333-265958-03, 333-265958-04 and 333-265958-05 of the Registrant, British American Tobacco Holdings (The Netherlands) B.V., Reynolds American Inc.,
B.A.T. Netherlands Finance B.V., B.A.T. International Finance p.l.c. and B.A.T Capital Corporation, and related Prospectuses, as such Registration Statements and Prospectuses may be amended from time to time.
EXHIBIT INDEX
|
Exhibit
|
|
Description
|
| |
||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
British American Tobacco p.l.c.
|
||||
|
|
By:
|
/s/ Claire Dhokia
|
||
| Name: |
Claire Dhokia
|
|||
| Title: |
Deputy Company Secretary
|
|||
Date: March 18, 2024
Exhibit 1
British American Tobacco p.l.c. (the “Company” or “BAT”)
18 March 2024
SHARE BUY-BACK PROGRAMME
As previously announced on 13 March 2024, BAT today commences its programme to buyback BAT ordinary shares (the “Programme”) using proceeds from sale of 436,851,457 ordinary shares
in ITC Limited. The final net proceeds received by the BAT Group were £1.57bn and the Programme will buy back £1.60bn of BAT ordinary shares starting with £700mn in 2024 and with the remaining £900mn in 2025. The Programme will commence on 18 March
2024 and will end no later than 31 December 2025.
The purpose of the Programme is to reduce the issued share capital of the Company. The purchased shares will be cancelled. The Company has entered into an agreement with UBS AG
London Branch (“UBS”) to enable the purchase of Ordinary Shares for the initial stage of the Programme. UBS will purchase the Company’s ordinary shares as principal and the Company will purchase such number of ordinary shares from UBS in accordance
with the terms of the engagement.
The number of ordinary shares permitted to be purchased by the Company, pursuant to the authority granted by the shareholders at the annual general meeting of the Company on 19 April
2023 (the “2023 AGM”), is 223,590,721 ordinary shares. The Programme will be carried out on Recognised Investment Exchanges within the UK. For the avoidance of doubt, no repurchases will be made in respect of the Company’s American Depositary
Receipts.
Any purchases of ordinary shares by the Company in relation to this announcement will be conducted in accordance with the Company’s general authority to repurchase shares granted by
its shareholders at the Company’s 2023 AGM and any further approvals to repurchase shares as may be granted by its shareholders from time to time, the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (2016/1052), in each case
as such legislation forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and Chapter 12 of the Financial Conduct Authority’s Listing Rules and will be discontinued in the event the Company ceases
to have the necessary general authority to repurchase ordinary shares.
Enquiries:
British American Tobacco Press Media Centre
+44 (0) 20 7845 2888 (24 hours) | @BATplc
Investor Relations
Victoria Buxton: +44 (0)20 7845 2012
Amy Chamberlain: +44 (0)20 7845 1124
Yetunde Ibe: +44 (0)20 7845 1095
John Harney: +44 (0)20 7845 1263
Jane Henderson: +44 (0)20 7845 1117